Medication info
Gontrol Tablet 10 mg (Ezetimibe)

Gontrol Tablet 10 mg (Ezetimibe)

Prescription medicationTablet
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Geonil Biopharm Co., Ltd.
Appearance
White to almost white oblong tablet
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201902435 · Approved 2019.04.19

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued while taking this medicine. The recommended dose of this medicine is 10 mg once daily, administered with or without food. When this medicine is coadministered with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate combination treatment at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, coadminister this medicine while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is coadministered with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). Administration to patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment. However, this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Administration to patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Administration to elderly patients No dosage adjustment is necessary when administering this medicine to elderly patients. Concomitant administration with bile acid sequestrants This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Ingredients

Manufacturer
Geonil Biopharm Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia

  • Primary hypercholesterolemia
  • elevated total cholesterol
  • elevated low-density lipoprotein cholesterol
  • elevated apolipoprotein B
  • mixed hyperlipidemia
  • elevated non-high-density lipoprotein cholesterol
  • homozygous familial hypercholesterolemia
  • elevated sitosterol
  • elevated campesterol
View approved original text

This medication helps lower blood cholesterol and lipid levels in patients with hyperlipidemia and phytosterolemia, such as primary hypercholesterolemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia, and homozygous sitosterolemia. It is particularly effective in improving vascular health by reducing total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and non-high-density lipoprotein cholesterol (non-HDL-C). This drug can be used alone or in combination with other lipid-lowering agents alongside dietary control, especially for patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. It is important to exclude and treat secondary causes of dyslipidemia before administration and to confirm treatment effectiveness with regular lipid tests. Overall, this medication contributes to reducing cardiovascular disease risk through the control of cholesterol and lipid levels.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued while taking this medicine. The recommended dose of this medicine is 10 mg once daily, administered with or without food. When this medicine is coadministered with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate combination treatment at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, coadminister this medicine while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is coadministered with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). Administration to patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment. However, this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Administration to patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Administration to elderly patients No dosage adjustment is necessary when administering this medicine to elderly patients. Concomitant administration with bile acid sequestrants This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Precautions

This medication should not be used in patients with hypersensitivity to certain components. In patients with active liver disease or significantly elevated liver enzyme levels, concomitant use with certain lipid-lowering agents should be avoided. Women who are pregnant or breastfeeding should be cautious as some lipid-lowering agents, including this one, are contraindicated in combination. The concomitant use of this medication with certain drugs is not recommended in patients with severely impaired liver function, gallbladder disease, or severe renal impairment. Patients with moderate or greater liver dysfunction may experience increased exposure to this drug, leading to unexpected side effects, so it should be used with caution. This medication is generally safe but may cause side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain; if symptoms persist, consult a physician. When used in combination with other lipid-lowering agents, there may be a slight increase in the risk of elevated liver enzyme levels or muscle-related side effects, necessitating regular monitoring. If symptoms such as muscle pain or weakness occur, medical personnel should be notified immediately, and medication may be discontinued if necessary. Patients with impaired renal function may also use this medication, but dose adjustment or caution may be required, so they should follow medical advice. This drug may interact with other medications, so it is essential to inform healthcare professionals of any concurrent medications. Women who are pregnant or planning to become pregnant should consult their physician before using this drug, and nursing women should also exercise caution. Use in children below 6 years of age is not recommended, and children over 6 should follow the guidance of healthcare providers. The elderly can generally use this medication, but attention is needed for age-related sensitivity differences. In cases of drug overdose, visit a medical institution immediately for proper treatment, and store out of reach of children.

Side effects

Fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, joint pain, low back pain, cough, chest pain, dizziness, headache, constipation, bloating, nausea, elevated AST, elevated ALT, myalgia, myopathy, rhabdomyolysis, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, pancreatitis, sensory disturbances, depression, cholelithiasis, cholecystitis, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanying drug reactions, erythema multiforme, drug-induced liver injury, chest discomfort, edema, asthenia, generalized edema, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, nasal discharge, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory infection, conjunctival injection, renal failure, abnormal liver function, increased serum creatinine, hypertension, increased blood urea, increased serum creatine phosphokinase, abnormal liver function tests, nausea

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture, ideally at room temperature between 1°C and 30°C. Storing it this way helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White to almost white oblong tablet

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.